NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-358-MEMO

1. 59055 HIV-LS-358; PUBMED-HIV-10/2/2006

Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1

Murga, JD, Franti, M, Pevear, DC, Maddon, PJ, and Olson, WC

Antimicrob Agents Chemother 2006. 50(10): 3289-96


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17005807&dopt=abstract


2. 59056 HIV-LS-358; PUBMED-HIV-10/2/2006

A platform for designing HIV integrase inhibitors. Part 2: A two-metal binding model as a potential mechanism of HIV integrase inhibitors

Kawasuji, T, Fuji, M, Yoshinaga, T, Sato, A, Fujiwara, T, and Kiyama, R

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17005407&dopt=abstract


3. 59057 HIV-LS-358; EMBASE-HIV-10/2/2006

Discovery of novel, highly potent and selective [beta]-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles

DeMarco, Steven J, Henze, Heiko, Lederer, Alexander, Moehle, Kerstin, Mukherjee, Reshmi, Romagnoli, Barbara, Robinson, John A, Brianza, Federico, Gombert, Frank O, and Lociuro, Sergio

Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4M0J4DK-2/2/8bfdbbcf0e7f402e2f8381a6f6771323


4. 59058 HIV-LS-358; PUBMED-HIV-10/2/2006

Synthesis and anti-HIV properties of new hydroxyquinoline-polyamine conjugates on cells infected by HIV-1 LAV and HIV-1 BaL viral strains

Moret, V, Dereudre-Bosquet, N, Clayette, P, Laras, Y, Pietrancosta, N, Rolland, A, Weck, C, Marc, S, and Kraus, JL

Bioorg Med Chem Lett 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17000109&dopt=abstract


5. 59059 HIV-LS-358; PUBMED-HIV-10/2/2006

Synthesis of neplanocin F analogues as potential antiviral agents

Zhang, H, Schinazi, RF, and Chu, CK

Bioorg Med Chem 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16996741&dopt=abstract



6. 59060 HIV-LS-358; PUBMED-HIV-10/2/2006

Tripfordines A-C, Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii, and Structure Anti-HIV Activity Relationships of Tripterygium Alkaloids

Horiuch, M, Murakami, C, Fukamiya, N, Yu, D, Chen, TH, Bastow, KF, Zhang, DC, Takaishi, Y, Imakura, Y, and Lee, KH

J Nat Prod 2006. 69(9): 1271-1274


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16989518&dopt=abstract


7. 59061 HIV-LS-358; PUBMED-HIV-10/2/2006

An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli

Pusch, O, Kalyanaraman, R, Tucker, LD, Wells, JM, Ramratnam, B, and Boden, D

AIDS 2006. 20 (15): 1917-1922


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16988512&dopt=abstract


8. 59062 HIV-LS-358; EMBASE-HIV-10/2/2006

Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment

Kagan, RM, Cheung, PK, Huard, TK, and Lewinski, MA

Antiviral Research 2006. 71(1): 42-52


HYPERLINK:

http://www.sciencedirect.com/science/article/B6T2H-4JJ85K4-1/2/36900955318aad7026fe4bce706b4384


9. 59063 HIV-LS-358; PUBMED-HIV-10/2/2006

In Vitro HIV-1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine

Margot, NA, Waters, JM, and Miller, MD

Antimicrob Agents Chemother 2006.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16982781&dopt=abstract


10. 59064 HIV-LS-358; PUBMED-HIV-10/2/2006

HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site

Skalova, T, Dohnalek, J, Duskova, J, Petrokova, H, Hradilek, M, Soucek, M, Konvalinka, J, and Hasek, J

J Med Chem 2006. 49(19): 5777-84


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16970402&dopt=abstract



11. 59065 HIV-LS-358; PUBMED-HIV-10/2/2006

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG

Abecasis, AB, Deforche, K, Bacheler, LT, McKenna, P, Carvalho, AP, Gomes, P, Vandamme, AM, and Camacho, RJ

Antivir Ther 2006. 11(5): 581-9


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16964826&dopt=abstract


12. 59066 HIV-LS-358; EMBASE-HIV-10/2/2006

The design, synthesis and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors

Yuan, Dekai, He, Meizi, Pang, Ruifang, Lin, Shrong-shi, Li, Zhengming, and Yang, Ming

Bioorganic & Medicinal Chemistry 2006. In Press, Accepted Manuscript


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4M10PJP-4/2/c9b983da7408a82cae5a5775b1cd9691


13. 59067 HIV-LS-358; EMBASE-HIV-10/2/2006

A platform for designing HIV integrase inhibitors. Part 1: 2-Hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores

Kawasuji, Takashi, Yoshinaga, Tomokazu, Sato, Akihiko, Yodo, Mitsuaki, Fujiwara, Tamio, and Kiyama, Ryuichi

Bioorganic & Medicinal Chemistry 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6TF8-4M0J4DK-1/2/57003eae34c240644c703c85b166721f


14. 59068 HIV-LS-358; EMBASE-HIV-10/2/2006

Three-dimensional quantitative structure-activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA

Nunthaboot, Nadtanet, Tonmunphean, Somsak, Parasuk, Vudhichai, Wolschann, Peter, and Kokpol, Sirirat

European Journal of Medicinal Chemistry 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6VKY-4M04DSV-1/2/444840f27a3bd905f9b341c5c4931141


15. 59069 HIV-LS-358; PUBMED-HIV-10/2/2006

Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development

Kadow, J, Wang, HG, and Lin, PF

Curr Opin Investig Drugs 2006. 7(8): 721-6


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16955683&dopt=abstract



16. 59070 HIV-LS-358; EMBASE-HIV-10/2/2006

Synergistic Inhibition of HIV-1 Envelope-Mediated Membrane Fusion by Inhibitors Targeting the N and C-Terminal Heptad Repeats of gp41

Gustchina, Elena, Louis, John M, Bewley, Carole A, and Clore, GMarius

Journal of Molecular Biology 2006. In Press, Corrected Proof


HYPERLINK:

http://www.sciencedirect.com/science/article/B6WK7-4KW5FHH-5/2/e52af45883fadd0219d4ac8873fb2630


17. 59071 HIV-LS-358; WOS-HIV-9/24/2006

Anti-HIV and toxicity of isolated compounds from Elaeodendron transvaalense

Tshikalange, TE, Meyer, JJM, and Ivars, F

SOUTH AFRICAN JOURNAL OF BOTANY 2006. 72(2): 334-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240298800119


18. 59072 HIV-LS-358; WOS-HIV-9/24/2006

Stereospecific synthesis of the (2R,3S)- and (2R,3R)-3-amino-2-hydroxy-4-phenylbutanoic acids from D-glucono-delta-lactone

Lee, JH, Kim, JH, Lee, BW, Seo, WD, Yang, MS, and Park, KH

BULLETIN OF THE KOREAN CHEMICAL SOCIETY 2006. 27(8): 1211-1218, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240394100023


19. 59073 HIV-LS-358; WOS-HIV-10/1/2006

Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase

D'Cruz, OJ and Uckun, FM

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2006. 21(4): 329-350, 22


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000240322000001


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021